NCT00694239已完成不适用
Evaluation of the Effect of Cardiovascular Risk Assessment in Treatment Compliance in Hypertension
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Medication Compliance
研究概览
简要总结
The RATCHET study assesses if patient knowledge of estimated cardiovascular risk at current and recommended target blood pressure levels improves compliance in the management of hypertension.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 30 Years 至 84 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Essential hypertension (new diagnosis or established diagnosis) meeting criteria for pharmacologic therapy as defined by current guidelines
排除标准
- •Lack of written informed consent
- •Previous myocardial infarction
- •Previous stroke
- •Congestive heart failure
- •Stage 3 or greater chronic kidney disease
- •Pregnancy
- •Usage of medication bubble/blister package
研究组 & 干预措施
B
No Intervention
Standard Care
A
Experimental
Risk Assessment plus standard care
干预措施: Knowledge of Cardiovascular Risk Assessment (Behavioral)
结局指标
主要结局
Medication Compliance
时间窗: 1 year
次要结局
- Patient perception of cardiovascular risk(1 year)
- Pilot Feasibility Study(1 year)
- Blood Pressure(1 year)
- Cholesterol Level(1 year)
- Framingham Risk Score (stroke and coronary artery disease)(1 year)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Knowledge of Cardiovascular Risk Factors in Chronic Kidney Disease PatientsChronic Kidney Disease(CKD)Renal TransplantationNCT06674031Hacettepe University28
Unknown
不适用
Cardiovascular Risk in Toledo PopulationCardiovascular Risk FactorCardiovascular DiseasesNCT03294369Castilla-La Mancha Health Service3,125
尚未招募
不适用
Cardiovascular Disease Risk of AwarenessCardiovascular DiseasesNCT06000436Necmettin Erbakan University54
Unknown
不适用
CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction II (COREA-AMI II)Percutaneous Coronary InterventionMajor Adverse Cardiovascular EventsBleedingAcute Myocardial InfarctionNCT02806102Seoul St. Mary's Hospital13,000
已完成
不适用
Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT)Ventricular ArrhythmiasHeart FailureNCT00996086Abbott Medical Devices154